S carcinomas (152). The presence of BRAF mutation within a serous borderline tumor is really
S carcinomas (152). The presence of BRAF mutation within a serous borderline tumor is really a favorable prognostic factor and may inhibit progression to low-grade serous cancer (153). A retrospective…